๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan ยท Delayed Price ยท Currency is JPY
69.00
-9.00 (-11.54%)
Nov 20, 2026, 3:30 PM JST

SymBio Pharmaceuticals Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,0591,3072,4525,58910,0088,257
Revenue Growth
-30.58%-46.70%-56.13%-44.16%21.21%176.42%
Gross Profit
778.139471,8734,4107,6005,804
Operating Income
-5,972-4,441-3,877-8121,9641,016
Net Income
-6,091-4,776-3,833-1,9621,1792,032
Earnings Per Share
-87.83-95.12-84.99-49.1729.7752.32
EPS Growth
-----43.10%-

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
253.992,8833,9636,5176,2823,860
Total Debt
8001,982----
Net Cash (Debt)
-546.019013,9636,5176,2823,860
Net Cash Growth
--77.27%-39.19%3.74%62.74%0.30%
Net Cash Per Share
-7.8717.9487.88163.32158.6299.38

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--4,575-3,416-1941,614140.04
Capital Expenditures
---19-204-2-25.45
Free Cash Flow
--4,575-3,435-3981,612114.59
Free Cash Flow Growth
----1306.78%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
73.48%72.46%76.39%78.91%75.94%70.30%
Operating Margin
-563.97%-339.79%-158.12%-14.53%19.62%12.31%
Pretax Margin
-571.11%-363.35%-155.26%-21.38%21.04%12.13%
Profit Margin
-575.15%-365.42%-156.32%-35.10%11.78%24.61%
FCF Margin
--350.04%-140.09%-7.12%16.11%1.39%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----21.5421.62
P/FCF Ratio
----15.76383.47
PS Ratio
5.503.843.721.872.545.32